Immunic, Inc.
Immunic, Inc.（IMUX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
imux · 股价预测 · 12 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 12 位华尔街分析师
Buy
12 位分析师
共识
评级分布
12 个月目标价
High
$22.00
Consensus
$14.50
+20.2% upside
Low
$2.50
Median: $19 · Last Close: $12.06
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$14.50
20.2% upside
High Target
$22
82.4%
Low Target
$2.5
-79.3%
Current Price
$12.06
as of today
Based on analyst price targets, the IMUX stock price prediction for the next 12 months ranges from $2.5 to $22. The consensus IMUX price forecast of $14.50 implies 20.2% upside from the current price of $12.06.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $12.39 | ↑ 2.76% |
1-day model range: $12.27–$12.51. Peak: $12.51 (+2.76%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $8 | -35.1% |
| 2028 | $6 | -46.4% |
| 2029 | $6 | -51.1% |
| 2030 | $6 | -53.3% |
| 2031 | — | -54.3% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IMUX · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-22 | B. Riley Securities | Maintains | Buy→Buy |
| 2026-04-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-15 | D. Boral Capital | Downgrade ↓ | Buy→Hold |
| 2026-03-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-13 | D. Boral Capital | Maintains | Buy→Buy |
| 2026-02-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-07 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-11-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-13 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-09-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Immunic, Inc. (IMUX) stock. Of the recent 48 rating actions, 0 were upgrades and 2 were downgrades. 12 analysts currently cover IMUX.
分析师推荐趋势
IMUX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$13M
↓ 79.2% YoY
Revenue Next Year
$13M
↑ 0.0% YoY
EPS This Year
$-4.38
EPS Next Year
$-3.55
↓ 19.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast IMUX EPS of $-4.38 for the current fiscal year, based on estimates from 8 analysts. The IMUX revenue forecast is $13M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
IMUX 股价预测由两类独立数据源支撑：来自 12 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。IMUX 的共识目标价为 $14.50（+20.2% 上行空间），分析师共识为 Buy。
IMUX 的短期预测（明日）为 $12.39（+2.76%）。 IMUX 对 2027 年的股价预测均值为 $8。 IMUX 对 2030 年的预测区间为 $5–$6。
Immunic, Inc. 在 NASDAQ 上市，代码 IMUX。IMUX 在 2027 年的整体展望偏积极，在覆盖分析师中约 83% 对应 Buy 共识。
常见问题
IMUX 预测 · 8 个问题根据 12 位华尔街分析师，IMUX 的 12 个月平均目标价为 $14.50，最高 $22.00、最低 $2.50。若有图表，中位目标价可在上方查看。相对当前价 $12.06，隐含约 +20.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.